PRNewsWire
16 Jan 2026, 01:00 UTC · 38w ago
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
Verdict
Headline leans bullish. We score 6996.HK +0.80.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · 6996.HK
+0.80strongly bullish





